STAMPEDE: Abiraterone results (Short version)

#ESMO21 Highlights on MFS analysis from comb. treatments in high-risk adv. prostate cancer: STAMPEDEПодробнее

STAMPEDE: Can radiotherapy help men with prostate cancer that has already spread? (Short version)Подробнее

Winship Grand Rounds July 19, 2017: Mehmet Asim Bilen, MDПодробнее

"Abiraterone saved my life." | Alfred's prostate cancer storyПодробнее

STAMPEDE: Abiraterone result (Full version)Подробнее

Abiraterone for the treatment of cN1 prostate cancerПодробнее

Stampede Trial : Androgen deprivation with and without AbirateroneПодробнее

Prostate Cancer: Clinical Guidelines, Novel Therapies, and Therapeutic UncertaintyПодробнее

5-year follow up of short-course abiraterone and ADT for high-risk prostate cancerПодробнее

STAMPEDE trial changes standard of care | Nicholas JamesПодробнее

STAMPEDE: Abiraterone acetate plus prednisolone or docetaxelПодробнее

Recent updates in prostate cancer: STAMPEDE, VISION & PROfoundПодробнее

EMUC18: STAMPEDE trialПодробнее

STAMPEDE: Does abiraterone (with or without enzalutamide) benefit men with prostate cancer?Подробнее

Results of the LATITUDE Trial in High-Risk Metastatic Hormone-Naive Prostate CancerПодробнее

PEACE-1 trialПодробнее

The STAMPEDE Trial: What Have We Learnt So Far?Подробнее

Results from ACIS Trial of Apalutamide + Abiraterone/Prednisone in Patients with Chemo-Naive mCRPCПодробнее

STAMPEDE Will 'Change Practice' in High-Risk Prostate Cancer - Medpage TodayПодробнее

Results from PEACE-1: abiraterone in mCSPCПодробнее